CSIMarket Company Name, Ticker, Competitors, else..


Coherus Biosciences inc   (NASDAQ: CHRS)
Other Ticker:  
 

Coherus Biosciences inc

CHRS's Fundamental analysis



Coherus Biosciences Inc 's sales fell by -5.09 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 653

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.31 %

Coherus Biosciences Inc net loss decreased from $-40 millions, to $-11 millions in III. Quarter 2024,

• More on CHRS's Growth


Coherus Biosciences Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Coherus Biosciences Inc PEG ratio is at -0.43 Company is currently trading with Price to Cash flow multiple of 8.29 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
43.92
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.47.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.61.


• More on CHRS's Valuation
 
 Total Debt (Millions $) 228
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 397,311
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 1.42
 Tangible Book Value (Per Share $) -1.24

Coherus Biosciences Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Coherus Biosciences Inc PEG ratio is at -0.43 Company is currently trading with Price to Cash flow multiple of 8.29 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
43.92
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.47.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.61.


• More on CHRS's Valuation

•  Market Capitalization (Millions $) 143
•  Shares Outstanding (Millions) 115
•  Employees 766
•  Revenues (TTM) (Millions $) 304
•  Net Income (TTM) (Millions $) 0
•  Cash Flow (TTM) (Millions $) 17
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) 228
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 397,311
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 1.42
•  Tangible Book Value (Per Share $) -1.24

•  Market Capitalization (Millions $) 143
•  Shares Outstanding (Millions) 115
•  Employees 766
•  Revenues (TTM) (Millions $) 304
•  Net Income (TTM) (Millions $) 0
•  Cash Flow (TTM) (Millions $) 17
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 1.25
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.47
•  Inventory Turnover Ratio (TTM) 2.87





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com